PreveCeutical Medical Inc Total Liabilities

Latest as of September 2025: €7.85 Million EUR ≈ $9.18 Million USD

PreveCeutical Medical Inc total liabilities. Based on the latest financial reports, PreveCeutical Medical Inc (18H) has total liabilities worth €7.85 Million EUR (≈ $9.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See PreveCeutical Medical Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Total Liabilities of PreveCeutical Medical Inc (2016–2024)

Total liabilities of PreveCeutical Medical Inc from 2016 to 2024. This chart illustrates how PreveCeutical Medical Inc's total liabilities have evolved over time, based on quarterly financial data.

PreveCeutical Medical Inc Competitors by Total Liabilities

The table below lists competitors of PreveCeutical Medical Inc ranked by their total liabilities.

Company	Country	Total Liabilities
GRI Bio Inc. NASDAQ:GRI	USA	$1.10 Million
Lithium Universe Ltd AU:LU7	Australia	AU$2.58 Million
EVE Health Group Limited AU:EVE	Australia	AU$307.63K
REDSUN PROPERTIES GROUP F:0RJ	Germany	€52.83 Billion
PT Trimuda Nuansa Citra Tbk JK:TNCA	Indonesia	Rp17.20 Billion
Pembroke VCT PLC LSE:PEMB	UK	GBX5.47 Million
Future PLC LSE:FUTR	UK	GBX623.30 Million
Whitemud Resources Inc V:WMK	Canada	CA$16.41 Million

Liability Composition Analysis (2016–2024)

This chart breaks down PreveCeutical Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 18H total assets.

Liquidity & Leverage Metrics

PreveCeutical Medical Inc Total Liabilities Ratios Explained

PreveCeutical Medical Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	17.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PreveCeutical Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PreveCeutical Medical Inc (2016–2024)

The table below shows the annual total liabilities of PreveCeutical Medical Inc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€6.86 Million ≈ $8.02 Million	+15.15%
2023-12-31	€5.96 Million ≈ $6.97 Million	+23.54%
2022-12-31	€4.82 Million ≈ $5.64 Million	+13.11%
2021-12-31	€4.27 Million ≈ $4.99 Million	+9.19%
2020-12-31	€3.91 Million ≈ $4.57 Million	-26.91%
2019-12-31	€5.34 Million ≈ $6.25 Million	+27.64%
2018-12-31	€4.19 Million ≈ $4.90 Million	+42.23%
2017-12-31	€2.94 Million ≈ $3.44 Million	+485.00%
2016-12-31	€503.24K ≈ $588.35K	--

About PreveCeutical Medical Inc

F:18H Germany Biotechnology

Market Cap

$3.34 Million

€2.85 Million EUR

Market Cap Rank

#29295 Global

#2536 in Germany

Share Price

€0.01

Change (1 day)

-54.55%

52-Week Range

€0.01 - €0.02

All Time High

€0.13